Press Releases

13 July 2017 WILEX reports first half 2017 results
19 June 2017 WILEX AG: Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates
11 May 2017 WILEX AG successfully completes rights issue
12 April 2017 WILEX AG: Interim management statement on the first three months of 2017
30 March 2017 WILEX announces financial figures for the 2016 fiscal year and reports on course of business
25 January 2017 WILEX AG: Subsidiary Heidelberg Pharma Exercises Option on BCMA Antibodies of the Max Delbrück Center and Signs License Agreement
16 January 2017 WILEX Signs Antibody License Agreement with Telix Pharmaceuticals Limited
Press Archive


Seite gelesen: 335676 | Heute: 351